AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35902868 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with unspecified parameters for larynx
Number of subjects: 74
Study 35902868 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with unspecified parameters for dysphagia
Number of subjects: 74
Study 35902868 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with unspecified parameters for thyroid
Number of subjects: 74
Study 35902868 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with Dmean ≥ 25.8 Gy for contralateral parotid gland
Number of subjects: 74
Study 34259458 — intervention group
Group type: EXPERIMENTAL
Intervention: IADPSG
Number of subjects: 921
Study 34259458 — intervention group
Group type: COMPARATOR
Intervention: Carpenter-Coustan
Number of subjects: 921
Study 32032736 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT on Life workshop (1-day intervention)
Number of subjects: 32
Study 32032736 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 32
Study 36387993 — intervention group
Group type: EXPERIMENTAL
Intervention: Kessler Foundation Strategy-based Training to Enhance Memory (KF-STEM™) - 8 sessions of cognitive rehabilitation training
Number of subjects: 120
Study 36387993 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 120
Study 32026537 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous extract of Cichorium intybus seeds (AECIS)
Number of subjects: 150
Study 32026537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 33096027 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg every 3 weeks)
Number of subjects: 148
Study 33096027 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus radiotherapy (24 Gy in three fractions or 50 Gy in four fractions or 45 Gy in 15 fractions)
Number of subjects: 148
Study 33099027 — intervention group
Group type: EXPERIMENTAL
Intervention: FAE for endometrial fluid (EF)
Number of subjects: 83
Study 33099027 — intervention group
Group type: COMPARATOR
Intervention: FAE for other indications (Control)
Number of subjects: 83
Study 32549196 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum Toxin Type A (BoNT‐A)
Number of subjects: 100
Study 32549196 — intervention group
Group type: COMPARATOR
Intervention: Oral appliance (OA)
Number of subjects: 100
Study 35975762 — intervention group
Group type: COMPARATOR
Intervention: Costoclavicular block (CCB) with 20 ml 0.5% ropivacaine
Number of subjects: 70
Study 35975762 — intervention group
Group type: EXPERIMENTAL
Intervention: Superior trunk block (STB) with 20 ml 0.5% ropivacaine
Number of subjects: 70
Study 35975762 — intervention group
Group type: COMPARATOR
Intervention: Costoclavicular block (CCB)
Number of subjects: 70
Study 33560138 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg daily
Number of subjects: 1522
Study 33560138 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 1522
Study 33560138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1522
Study 37436461 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cord clamping (ECC) (< 10 s postpartum)
Number of subjects: 96
Study 37436461 — intervention group
Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC) (45‐60 s postpartum)
Number of subjects: 96
Study 34461322 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine and rosuvastatin in addition to standard of care (SOC)
Number of subjects: 466
Study 34461322 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 466
Study 33757609 — intervention group
Group type: EXPERIMENTAL
Intervention: Levomilacipran (LVM)
Number of subjects: 17
Study 33757609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 33757609 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined LVM and placebo groups
Number of subjects: 17
Study 33685404 — intervention group
Group type: EXPERIMENTAL
Intervention: Dense V‐Net
Number of subjects: 133
Study 32690499 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI every 14 days until disease progression or unacceptable toxicity or for a maximum of 6 months
Number of subjects: 112
Study 32690499 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPTEM every 28 days until disease progression or unacceptable toxicity or for a maximum of 6 months
Number of subjects: 112
Study 34355872 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 133
Study 34355872 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 133
Study 34965006 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract encapsulated chitosan microparticles (GTP) cream
Number of subjects: 29
Study 34965006 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 29
Study 36231378 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga and mindfulness intervention
Number of subjects: 0
Study 36231378 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 36231378 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall time effect
Number of subjects: 0
Study 36231378 — intervention group
Group type: EXPERIMENTAL
Intervention: Time by group effect
Number of subjects: 0
Study 33787834 — intervention group
Group type: EXPERIMENTAL
Intervention: Revacept 160 mg
Number of subjects: 334
Study 33787834 — intervention group
Group type: EXPERIMENTAL
Intervention: Revacept 80 mg
Number of subjects: 334
Study 33787834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 334
Study 35680173 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined metabolic medication (SINR) containing succinic acid, inosine, nicotinamide, and riboflavin, administered intravenously for 10 days followed by oral administration for 75 days
Number of subjects: 216
Study 35680173 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered intravenously for 10 days followed by oral administration for 75 days
Number of subjects: 216
Study 35680173 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined metabolic medication (SINR)
Number of subjects: 216
Study 34060685 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical manual therapy plus conventional physiotherapy
Number of subjects: 46
Study 34060685 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 46
Study 36122966 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐administered condition‐tailored psychoeducational intervention
Number of subjects: 418
Study 36122966 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 418
Study 33517762 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month interdisciplinary program
Number of subjects: 108
Study 36115616 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-injection liposomal bupivacaine brachial plexus nerve block (LB)
Number of subjects: 63
Study 36115616 — intervention group
Group type: COMPARATOR
Intervention: Interscalene catheter (ISC)
Number of subjects: 63
Study 32979417 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 217
Study 32979417 — intervention group
Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 217
Study 35745210 — intervention group
Group type: EXPERIMENTAL
Intervention: Active beetroot juice (BJ) - 70 mL, 400 mg nitrate
Number of subjects: 15
Study 35745210 — intervention group
Group type: COMPARATOR
Intervention: Placebo beetroot juice (BJ) - 70 mL, 0 mg nitrate
Number of subjects: 15
Study 35745210 — intervention group
Group type: EXPERIMENTAL
Intervention: Active beetroot juice (BJ)
Number of subjects: 15
Study 35745210 — intervention group
Group type: COMPARATOR
Intervention: Placebo beetroot juice (BJ)
Number of subjects: 15
Study 34024686 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (DAPA)
Number of subjects: 45
Study 34024686 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 45
Study 32828503 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-treated colostrum (60°C, 60 min)
Number of subjects: 22
Study 32828503 — intervention group
Group type: COMPARATOR
Intervention: Raw colostrum
Number of subjects: 22
Study 35109403 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive, individualized, person-centered management (CI-PCM)
Number of subjects: 0
Study 35109403 — intervention group
Group type: COMPARATOR
Intervention: Usual Community Care (UCC)
Number of subjects: 0
Study 32410578 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk feed type
Number of subjects: 398
Study 32410578 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in milk feed type
Number of subjects: 398
Study 32410578 — intervention group
Group type: COMPARATOR
Intervention: Matched controls from the same population
Number of subjects: 398
Study 36454571 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing glasses (e.g., sunglasses) in public spaces for 2 weeks
Number of subjects: 3717
Study 36454571 — intervention group
Group type: COMPARATOR
Intervention: Control group (no glasses)
Number of subjects: 3717
Study 33823167 — intervention group
Group type: EXPERIMENTAL
Intervention: Busulfan/melphalan (BuMel) ASCT
Number of subjects: 146
Study 34417920 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support score categories (7-10 points)
Number of subjects: 88
Study 34417920 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support score categories (≥ 11 points)
Number of subjects: 88
Study 34244212 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibition of Scavenger Receptor B1 (SCARB1)
Number of subjects: 0
Study 34244212 — intervention group
Group type: EXPERIMENTAL
Intervention: Deprivation of cholesterol or HDL
Number of subjects: 0
Study 34244212 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated dietary cholesterol
Number of subjects: 0
Study 34244212 — intervention group
Group type: COMPARATOR
Intervention: Mendelian randomization analyses based on 31,000 individuals
Number of subjects: 0
Study 32012255 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete Response (CR)
Number of subjects: 601
Study 32012255 — intervention group
Group type: COMPARATOR
Intervention: Partial Response (PR) or No Response (NR)
Number of subjects: 601
Study 32012255 — intervention group
Group type: EXPERIMENTAL
Intervention: CR status in patients with PM primary site
Number of subjects: 601
Study 32012255 — intervention group
Group type: EXPERIMENTAL
Intervention: CR status in patients with non-PM primary sites
Number of subjects: 601
Study 32012255 — intervention group
Group type: COMPARATOR
Intervention: Resection of the end-of-therapy mass
Number of subjects: 601
Study 32012255 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic response
Number of subjects: 601
Study 32929855 — intervention group
Group type: EXPERIMENTAL
Intervention: SCA 40%
Number of subjects: 10
Study 32929855 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 10
Study 36490202 — intervention group
Group type: EXPERIMENTAL
Intervention: Debiasing checklist
Number of subjects: 42
Study 36490202 — intervention group
Group type: EXPERIMENTAL
Intervention: Content-specific checklist
Number of subjects: 42
Study 36490202 — intervention group
Group type: COMPARATOR
Intervention: No checklist
Number of subjects: 42
Study 36490202 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist use (both types)
Number of subjects: 42
Study 33896812 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy (APM)
Number of subjects: 192
Study 33896812 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid injection (HAI) with APM
Number of subjects: 192
Study 33896812 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy (PT)
Number of subjects: 192
Study 33896812 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid injection (HAI) with PT
Number of subjects: 192
Study 33896812 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 192
Study 32075993 — intervention group
Group type: COMPARATOR
Intervention: Pulsed electromagnetic fields (PEMFs); specific details on dosage and duration are not available.
Number of subjects: 3
Study 32075993 — intervention group
Group type: COMPARATOR
Intervention: Placebo; specific details on dosage and duration are not available.
Number of subjects: 3
Study 36067089 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (CTD)
Number of subjects: 34
Study 36067089 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 34
Study 36067089 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (ASA)
Number of subjects: 34
Study 34373298 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 0
Study 34373298 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 0
Study 34373298 — intervention group
Group type: COMPARATOR
Intervention: Education
Number of subjects: 0
Study 36152636 — intervention group
Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation
Number of subjects: 42
Study 36152636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 32920556 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational program for caregivers
Number of subjects: 0
Study 32920556 — intervention group
Group type: COMPARATOR
Intervention: Non-psychoeducated caregivers
Number of subjects: 0
Study 36705750 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (SB) supplementation (0.3 g·kg‐1 BM)
Number of subjects: 11
Study 36705750 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 11
Study 36705750 — intervention group
Group type: COMPARATOR
Intervention: Familiarisation (FAM)
Number of subjects: 11
Study 32167433 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg polyphenols extracted from seeds of red grape (Nero di Troia cultivar) (NATUR‐OX®) for 3 months (T1)
Number of subjects: 50
Study 32167433 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months (T1)
Number of subjects: 50
Study 32740283 — intervention group
Group type: EXPERIMENTAL
Intervention: HealthTRAC
Number of subjects: 38
Study 32740283 — intervention group
Group type: COMPARATOR
Intervention: SBWC
Number of subjects: 38
Study 36104787 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS combined with FCE
Number of subjects: 30
Study 36104787 — intervention group
Group type: COMPARATOR
Intervention: Sham combined with FCE (control group)
Number of subjects: 30
Study 36104787 — intervention group
Group type: COMPARATOR
Intervention: FCE alone
Number of subjects: 30
Study 33764636 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg three times per day plus guideline-recommended treatment for heart failure
Number of subjects: 80
Study 33764636 — intervention group
Group type: COMPARATOR
Intervention: Guideline-recommended treatment for heart failure (ACEIs or ARBs, beta-blockers, aldosterone receptor antagonist, digoxin)
Number of subjects: 80
Study 32320002 — intervention group
Group type: EXPERIMENTAL
Intervention: High oro-sensory exposure (OSE) with slow eating rate (ER)
Number of subjects: 60
Study 32320002 — intervention group
Group type: EXPERIMENTAL
Intervention: Low oro-sensory exposure (OSE) with fast eating rate (ER)
Number of subjects: 60
Study 32320002 — intervention group
Group type: EXPERIMENTAL
Intervention: High oro-sensory exposure (OSE)
Number of subjects: 60
Study 32320002 — intervention group
Group type: COMPARATOR
Intervention: Low oro-sensory exposure (OSE)
Number of subjects: 60
Study 35086247 — intervention group
Group type: EXPERIMENTAL
Intervention: Single para-muscular (SPM) approach
Number of subjects: 36
Study 35086247 — intervention group
Group type: COMPARATOR
Intervention: Standard para limbal (SPL) approach
Number of subjects: 36
Study 35086247 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SPM and SPL approaches
Number of subjects: 36
Study 32618780 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone bagging therapy at 70 μg/mL for 10 minutes every 3 days for 21 days
Number of subjects: 27
Study 32618780 — intervention group
Group type: COMPARATOR
Intervention: Standard wound care with antimicrobial dressings every 3 days for 21 days
Number of subjects: 27
Study 34251445 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 205
Study 34251445 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 205
Study 34251445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study 35027821 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaraminol
Number of subjects: 75
Study 35027821 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 75
Study 35027821 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine
Number of subjects: 75
Study 34463270 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine
Number of subjects: 22
Study 36039391 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% topical minoxidil solution
Number of subjects: 120
Study 36039391 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% topical spironolactone solution
Number of subjects: 120
Study 36039391 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% topical minoxidil and spironolactone combination
Number of subjects: 120
Study 36039391 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study 35000943 — intervention group
Group type: EXPERIMENTAL
Intervention: NaviTip FX irrigation system
Number of subjects: 90
Study 35000943 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibringe sonic irrigation system
Number of subjects: 90
Study 35000943 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoVac apical negative pressure irrigation system
Number of subjects: 90
Study 33838737 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified houses (improved housing with metal roofs and screened doors/windows)
Number of subjects: 805
Study 33838737 — intervention group
Group type: COMPARATOR
Intervention: Unmodified houses (traditional housing)
Number of subjects: 805
Study 32524862 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg two times per day for 5 days
Number of subjects: 12
Study 35935305 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-determination theory management
Number of subjects: 90
Study 34330321 — intervention group
Group type: EXPERIMENTAL
Intervention: SurgeryPalTM (digital peri-operative cognitive-behavioral intervention)
Number of subjects: 400
Study 34330321 — intervention group
Group type: COMPARATOR
Intervention: Education control
Number of subjects: 400
Study 32199569 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding of AEBS trigger conditions (TCs)
Number of subjects: 800
Study 32199569 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition of AEBS does not work properly
Number of subjects: 800
Study 32199569 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition of AEBS works accidentally
Number of subjects: 800
Study 36172702 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop phase using DBLG1 hybrid closed-loop solution
Number of subjects: 45
Study 34472896 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive remediation therapy (CRT) with 8 group sessions over 2 months
Number of subjects: 270
Study 34472896 — intervention group
Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 270
Study 34472896 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive remediation therapy (CRT)
Number of subjects: 270
Study 32697872 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-assisted cytology
Number of subjects: 703103
Study 32697872 — intervention group
Group type: COMPARATOR
Intervention: Manual reading
Number of subjects: 703103
Study 33719084 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant factor VIII Fc fusion protein (rFVIIIFc) dosed at 40 IU/kg every 2 days
Number of subjects: 0
Study 35017617 — intervention group
Group type: EXPERIMENTAL
Intervention: linagliptin (5 mg) + insulin
Number of subjects: 73
Study 35017617 — intervention group
Group type: COMPARATOR
Intervention: insulin alone
Number of subjects: 73
Study 32889844 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal DEX gel 0.5 µg/kg
Number of subjects: 36
Study 32889844 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal DEX gel 0.75 µg/kg
Number of subjects: 36
Study 32889844 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal DEX gel 1 µg/kg
Number of subjects: 36
Study 33086352 — intervention group
Group type: EXPERIMENTAL
Intervention: Detsky quality-of-reporting index (Detsky score)
Number of subjects: 285
Study 33086352 — intervention group
Group type: COMPARATOR
Intervention: Multicenter RCTs
Number of subjects: 285
Study 33086352 — intervention group
Group type: COMPARATOR
Intervention: Positive trials
Number of subjects: 285
Study 33086352 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression analysis
Number of subjects: 285
Study 33086352 — intervention group
Group type: COMPARATOR
Intervention: Methodology scores
Number of subjects: 285
Study 33086352 — intervention group
Group type: COMPARATOR
Intervention: Risk-of-bias assessment
Number of subjects: 285
Study 34569457 — intervention group
Group type: EXPERIMENTAL
Intervention: Tummy time instruction (n = 20)
Number of subjects: 64
Study 34569457 — intervention group
Group type: EXPERIMENTAL
Intervention: Tummy time + outpatient reinforcement (n = 21)
Number of subjects: 64
Study 34569457 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (n = 23)
Number of subjects: 64
Study 34569457 — intervention group
Group type: EXPERIMENTAL
Intervention: Tummy time >15 minutes daily
Number of subjects: 64
Study 34569457 — intervention group
Group type: EXPERIMENTAL
Intervention: Tummy time <15 minutes daily
Number of subjects: 64
Study 36430138 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided adductor canal block (ACB), n = 15
Number of subjects: 31
Study 36430138 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 mL of 1% lidocaine), n = 16
Number of subjects: 31
Study 32397852 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical phenylephrine hydrochloride
Number of subjects: 48
Study 32397852 — intervention group
Group type: EXPERIMENTAL
Intervention: RJ101 (norepinephrine releasing agent)
Number of subjects: 48
Study 32397852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 35365604 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline allostatic load (AL)
Number of subjects: 0